David J. Webb

Active 1983–2025

Also published as
David J Webb
214
Papers
40,334
Citations
112
h-index
200
i10-index

Citations

Citations per year for David J. Webb1984: 1 citations1985: 3 citations1986: 2 citations1987: 1 citations1988: 2 citations1989: 2 citations1990: 2 citations1991: 1 citations1992: 2 citations1993: 5 citations1994: 18 citations1995: 21 citations1996: 30 citations1997: 27 citations1998: 66 citations1999: 105 citations2000: 127 citations2001: 161 citations2002: 169 citations2003: 183 citations2004: 182 citations2005: 228 citations2006: 230 citations2007: 236 citations2008: 247 citations2009: 271 citations2010: 311 citations2011: 269 citations2012: 382 citations2013: 326 citations2014: 378 citations2015: 360 citations2016: 371 citations2017: 344 citations2018: 323 citations2019: 984 citations2020: 1,112 citations2021: 924 citations2022: 707 citations2023: 603 citations2024: 967 citations2025: 550 citations2026: 30 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,970 citing papers, 20.5% of this breakdownUnited Kingdom: 1,810 citing papers, 12.5% of this breakdownChina: 935 citing papers, 6.5% of this breakdownItaly: 755 citing papers, 5.2% of this breakdownGermany: 659 citing papers, 4.5% of this breakdownAustralia: 549 citing papers, 3.8% of this breakdownFrance: 484 citing papers, 3.3% of this breakdownCanada: 463 citing papers, 3.2% of this breakdownNetherlands: 439 citing papers, 3% of this breakdownSpain: 396 citing papers, 2.7% of this breakdownJapan: 366 citing papers, 2.5% of this breakdownSweden: 357 citing papers, 2.5% of this breakdown
0%20.5%Other 29.8%

Fields

  • Medicine67.1%
  • Biochemistry, Genetics and Molecular Biology15.6%
  • Engineering3.1%
  • Immunology and Microbiology2.6%
  • Neuroscience2.5%
  • Pharmacology, Toxicology and Pharmaceutics2.1%
  • Other7%

Topics

  • Cardiovascular Health and Disease Prevention5.3%
  • Nitric Oxide and Endothelin Effects4.3%
  • Blood Pressure and Hypertension Studies4%
  • Heart Rate Variability and Autonomic Control2.1%
  • Hormonal Regulation and Hypertension1.9%
  • Extracellular vesicles in disease1.8%
  • Other80.6%

Coauthors

All papers

Open in search
  1. Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial

    Authors: , , , , , , , , , , , , - The Lancet 2015 cited by 1,245

  2. Aortic Pulse Wave Velocity Improves Cardiovascular Event Prediction

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ian B. Wilkinson - Journal of the American College of Cardiology 2013 cited by 1,803

  3. Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension

    Authors: , , , , , , , , , , - New England Journal of Medicine 2023 cited by 261

  4. Endothelin

    Authors: , , , , , , , , - Pharmacological Reviews 2016 cited by 753

  5. Acute Blood Pressure Lowering, Vasoprotective, and Antiplatelet Properties of Dietary Nitrate via Bioconversion to Nitrite

    Authors: , , , , , , , , , , , , - Hypertension 2008 cited by 1,076

  6. Small interfering RNA: Discovery, pharmacology and clinical development—An introductory review

    Authors: , , , - British Journal of Pharmacology 2022 cited by 122

  7. Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial

    Authors: , , , , , , , , , , , , , , , , - The Lancet 2022 cited by 216

  8. The revision of the Declaration of Helsinki: past, present and future

    Authors: , , - British Journal of Clinical Pharmacology 2004 cited by 719

  9. Modelling estimates of the burden of Respiratory Syncytial virus infection in adults and the elderly in the United Kingdom

    Authors: , , , , , , , , - BMC Infectious Diseases 2015 cited by 245

  10. A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation

    Authors: , , , - American Journal of Clinical Nutrition 2007 cited by 751

  11. Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , See Kwok, P Lacy, I. MacIntyre, Judith Mackay, Nirmala D. Markandu, Una Martin, Linsay McCallum, Gerry P McCann, Andrew W. McGinnis, Vanessa Melville, S. Muir, KS Myint, Salik Nazir, J. Palmer, Richard Papworth, Krzysztof Rutkowski, Manjari Saxena, A. Schumann, Handrean Soran, A Stanley, Simon Thom, David J. Webb, C.W. White, Robert Wilson, Zák A - The Lancet Diabetes & Endocrinology 2018 cited by 331

  12. Physiological Stratification of Patients With Angina Due to Coronary Microvascular Dysfunction

    Authors: , , , , , , , , - Journal of the American College of Cardiology 2020 cited by 161

  13. Dysfunctional and Dysregulated Nitric Oxide Synthases in Cardiovascular Disease: Mechanisms and Therapeutic Potential

    Authors: , , , - International Journal of Molecular Sciences 2023 cited by 109

  14. Identification and proteomic profiling of exosomes in human cerebrospinal fluid

    Authors: , , , , , , , , - Journal of Translational Medicine 2012 cited by 473

  15. Endothelins in cardiovascular biology and therapeutics

    Authors: , - Nature Reviews Cardiology 2019 cited by 239

  16. Coronary Microvascular Dysfunction Is Associated With Myocardial Ischemia and Abnormal Coronary Perfusion During Exercise

    Authors: , , , , , , , , , , , - Circulation 2019 cited by 212

  17. The eye, the kidney, and cardiovascular disease: old concepts, better tools, and new horizons

    Authors: , , , , - Kidney International 2020 cited by 165

  18. Epilepsy, suicidality, and psychiatric disorders: A bidirectional association

    Authors: , , , , , - Annals of Neurology 2012 cited by 594

  19. Inorganic Nitrate Supplementation Lowers Blood Pressure in Humans

    Authors: , , , , , , , , , , , , , - Hypertension 2010 cited by 607

  20. Long‐term adverse effects of paracetamol – a review

    Authors: , , , , - British Journal of Clinical Pharmacology 2018 cited by 290

  21. Pulse transit time measured from the ECG: an unreliable marker of beat-to-beat blood pressure

    Authors: , , , - Journal of Applied Physiology 2005 cited by 419

  22. Established and emerging therapeutic uses of PDE type 5 inhibitors in cardiovascular disease

    Authors: , , , - British Journal of Pharmacology 2019 cited by 113

  23. ChaMP-CMD: A Phenotype-Blinded, Randomized Controlled, Cross-Over Trial

    Authors: , , , , , , , , , , , , , , , - Circulation 2023 cited by 58

  24. The influence of heart rate on augmentation index and central arterial pressure in humans

    Authors: , , , , , - The Journal of Physiology 2000 cited by 1,084